Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Prostate cancer

  • Open Access
    Improved Analysis of Prostate Cancer: VIM3, ATG7 and P53 Form a Complex and Activate miRNA 371a-3p
    ELENA K. NOHL, JASMIN BEHRING, ERSEN KAMERI, BARBARA KÖDITZ, TIM NESTLER, AXEL HEIDENREICH and MELANIE VON BRANDENSTEIN
    Anticancer Research June 2023, 43 (6) 2407-2416; DOI: https://doi.org/10.21873/anticanres.16408
  • Open Access
    Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells
    TAKAFUMI SHIMADA, RENATO NAITO, REN TORIUMI, RYUNOSUKE NAKAGAWA, SHUHEI AOYAMA, TAIKI KAMIJIMA, HIROSHI KANO, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, KOUJI IZUMI, YOSHIFUMI KADONO, HIROKI NAKATA, YOHEI SAITO, KYOKO NAKAGAWA-GOTO and ATSUSHI MIZOKAMI
    Anticancer Research June 2023, 43 (6) 2433-2444; DOI: https://doi.org/10.21873/anticanres.16411
  • You have access
    The CCL2–CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells
    ARIUNBOLD NATSAGDORJ, KOUJI IZUMI, KAORU HIRATSUKA, RENATO NAITO, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, KAZUYOSHI SHIGEHARA, HIROKI NAKATA and ATSUSHI MIZOKAMI
    Anticancer Research June 2023, 43 (6) 2561-2569; DOI: https://doi.org/10.21873/anticanres.16423
  • Open Access
    Safety of Carbon-ion Radiotherapy for Prostate Cancer After Rectal Cancer Surgery
    YOSUKE TAKAKUSAGI, HIROAKI KOGE, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, DAISAKU YOSHIDA, TADASHI KAMADA and HIROYUKI KATOH
    Anticancer Research June 2023, 43 (6) 2691-2695; DOI: https://doi.org/10.21873/anticanres.16435
  • You have access
    In Vivo Dosimetry in the Urethra During Prostate Carbon Ion Radiotherapy
    SHINNOSUKE MATSUMOTO, NARUHIRO MATSUFUJI, YUSUKE KOBA and HIROSHI TSUJI
    Anticancer Research May 2023, 43 (5) 2259-2264; DOI: https://doi.org/10.21873/anticanres.16389
  • Open Access
    Reinforcement of the Tumor Suppressing Properties of microRNA-1 by Substitution at the C2′ Position of Varying Ribose Residues in Chemically Synthesized microRNA-1 Molecules
    HANNES AHREND, BETTINA APPEL, LISA JUNG, SABINE MÜLLER and MATTHIAS B. STOPE
    Anticancer Research May 2023, 43 (5) 1909-1918; DOI: https://doi.org/10.21873/anticanres.16350
  • Open Access
    Prevalence and Risk Factors of Emotional Distress in Patients With Prostate Cancer Assigned to External-beam Radiotherapy With or Without High-dose Rate Brachytherapy
    AHMED AL-SALOOL, TAMER SOROR, NATHAN Y. YU and DIRK RADES
    Anticancer Research May 2023, 43 (5) 2103-2109; DOI: https://doi.org/10.21873/anticanres.16371
  • You have access
    Comparison of Quality of Life and Injection Site Reactions After Switching from Degarelix 80 mg to 480 mg in Advanced Prostate Cancer: A Prospective Trial
    KEIICHIRO MIYAJIMA, TAKAFUMI YANAGISAWA, HIROTAKA SUZUKI, WATARU FUKUOKAYA, KEIGO SAKANAKA, KOKI OBAYASHI, JUN MIKI and TAKAHIRO KIMURA
    Anticancer Research April 2023, 43 (4) 1611-1621; DOI: https://doi.org/10.21873/anticanres.16311
  • You have access
    Optimization of Fluence Map for CyberKnife Raster Scanning Intensity Modulated Radiotherapy
    YUICHI AKINO, HIROYA SHIOMI, NOBUHISA MABUCHI, NORIHISA MASAI, RYOONG-JIN OH and KAZUHIKO OGAWA
    Anticancer Research April 2023, 43 (4) 1637-1642; DOI: https://doi.org/10.21873/anticanres.16314
  • You have access
    Serum Thymidine Kinase 1 – Potential Prostate Cancer Biomarker: A Clinical Study
    JAKUB REZAC, LENKA HANOUSKOVA, STEPAN VESELY, KAREL KOTASKA, ALZBETA KANTOROVA, ANNA LINHARTOVA, VOJTECH FIALA, VIKTOR SOUKUP and OTAKAR CAPOUN
    Anticancer Research April 2023, 43 (4) 1675-1680; DOI: https://doi.org/10.21873/anticanres.16319

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 30
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire